Due to known spikes in blood glucose levels in acutely ill patients with or without known diabetes, basal-bolus treatment regimen is recommended for non-critical ill patients’ hyperglycemia management, as it most closely mimics the body’s normal patterns of insulin secretion [2]. The gene discussed is INS; the disease is diabetes mellitus.